Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,141 | -2,711 | -11,629 | -9,353 | -6,473 |
| Depreciation Amortization | 9 | 5 | 35 | 30 | 20 |
| Accounts receivable | 57 | 53 | -36 | -24 | -28 |
| Other Working Capital | 511 | 355 | -660 | -249 | 415 |
| Other Operating Activity | 958 | 447 | 2,072 | 1,612 | 888 |
| Operating Cash Flow | $-4,606 | $-1,851 | $-10,218 | $-7,984 | $-5,178 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | -201 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-201 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 26,040 | 26,040 | 26,040 |
| Debt Repayment | -1,378 | -683 | -1,991 | -1,320 | -657 |
| Other Financing Activity | -227 | -120 | -2,738 | -2,607 | -2,472 |
| Financing Cash Flow | $-1,605 | $-803 | $21,311 | $22,113 | $22,911 |
| Exchange Rate Effect | -20 | -2 | -19 | -24 | 2 |
| Beginning Cash Position | 14,829 | 14,829 | 3,957 | 3,957 | 3,957 |
| End Cash Position | 8,598 | 12,174 | 14,829 | 18,063 | 21,692 |
| Net Cash Flow | $-6,232 | $-2,655 | $10,872 | $14,105 | $17,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,606 | -1,851 | -10,218 | -7,984 | -5,178 |
| Free Cash Flow | -4,606 | -1,851 | -10,218 | -7,984 | -5,178 |